Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jun 28, 2016; 22(24): 5578-5588
Published online Jun 28, 2016. doi: 10.3748/wjg.v22.i24.5578
Table 1 Genotypes of 13 patients diagnosed with very early-onset inflammatory bowel disease
PatientGeneVariationHomo/HeterozygoteFunction defect
1IL-10RAp.R101WHomozygoteYes
2IL-10RAp.R101WCompound heterozygoteYes
p.V100G (novel mutation)Pathogenic supporting by Polyphen 2 and SIFT
3IL-10RAp.R101WCompound heterozygoteYes
p.Y64C (novel mutation)Pathogenic supporting by Polyphen 2 and SIFT
4IL-10RAp.R117H (rs199989396)HeterozygoteYes
NOD2p.R703C (rs5743277)HeterozygoteSusceptibility to CD recorded in HGMD
FUT2p.I140F (rs1047781)HeterozygoteSusceptibility to CD in Chinese population reported by Hu et al[31]
5IL-10RBp.K47E (rs2834167)HomozygoteSNP in a VEO-UC child reported by Galatola et al[29]
p.E141K (rs387907326)HeterozygotePathogenic supporting by Polyphen 2 and SIFT
IL-10RAp.P115P (rs22280554)HomozygoteSusceptibility to VEO-IBD reported by Moran et al[30]
p.I224V (rs22280555)Homozygote
FUT2p.I140F (rs1047781)HeterozygoteSusceptibility to CD in Chinese population reported by Hu et al[31]
6IL-10RAp.P115P (rs22280554)HomozygoteSusceptibility to VEO-IBD reported by Moran et al[30]
p.I224V (rs22280555)Homozygote
FUT2p.I140F (rs1047781)HomozygoteSusceptibility to CD in Chinese population reported by Hu et al[31]
7IL-10RAp.P115P (rs22280554)HomozygoteSusceptibility to VEO-IBD reported by Moran et al[30]
p.I224V (rs22280555)Homozygote
FUT2p.I140F (rs1047781)HeterozygoteSusceptibility to CD in Chinese population reported by Hu et al[31]
8IL-10RBp.K47E (rs2834167)HomozygoteSNP in a VEO-UC child reported by Galatola et al[29]
FUT2p.I140F (rs1047781)HeterozygoteSusceptibility to CD in Chinese population reported by Hu et al[31]
9IL-10RBp.K47E (rs2834167)HeterozygoteSNP in a VEO-UC child reported by Galatola et al[29]
FUT2p.I140F (rs1047781)HeterozygoteSusceptibility to CD in Chinese population reported by Hu et al[31]